The largest database of trusted experimental protocols
> Procedures > Therapeutic or Preventive Procedure > Emergency Contraception

Emergency Contraception

Discover how PubCompare.ai empowers reproductive health researchers to streamline their research on emergency contraception.
Locate the latest protocols from literature, preprints, and patents, then leverage AI-driven analysis to identify the most effective protocols and products.
Optimize your research with PubCompare.ai's powerful tools, and stay ahead of the curve in this critical area of reproductive health.

Most cited protocols related to «Emergency Contraception»

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2010
Clinical Protocols Clinic Visits Condoms Contraceptive Methods Counselors Emergency Contraception Harm Reduction Patients Pregnancy Reading Frames Reproduction Sexual Assault Sexual Health Specialists Teaching Victimization Woman
We reviewed existing literature and more than 30 instruments on fertility preferences and reasons for non-use of contraception conducted in low-, middle-, and high-income countries, and compiled question items by themes. This includes instruments from the DHS, the Determinants of Unintended Pregnancy Risk study in New Orleans, the US- based National Survey of Family Growth, and the Fog Zone study by the Guttmacher Institute. Subsequently, a new questionnaire was developed using the compilation of the question items. A draft instrument was reviewed through consultative process with dozens of experts in the field.
The questionnaire has three main components: a sub-set of DHS items measuring socio-demographic characteristics, reproductive history, and sexual activity; additional questions on prospective and retrospective fertility preferences designed to capture ambivalence and uncertainty; and two large blocks of items on (i) generic concerns about contraception and (ii) method-specific attributes. The method-specific items encompass eight modern and traditional methods. A list of selected question items is presented in Table 1.

List of selected question items

CategoryQuestion items
Background characteristics of women and husbands/partnersAge, level of education, current marital status and history, occupation including casual work, religion, co-residential status with husband/partner, ethnicity (only in Kenya), perceived risk of HIV infection (only Homa-Bay)
ReproductionParity, number of living children, age of the last child, current pregnancy status, duration of pregnancy, outcome of pregnancy at round 2 and 3 (live births, survival status, miscarriages, abortions)
Past, current and future contraceptive useKnowledge of contraceptive methods, current use (month-to-month use at round 2 and 3), use of emergency contraception, reasons for non-use, intention for future use, preferred method, intention to switch a method
(1) Fertility preferences
  Prospective fertility preferencesFuture desire for children, preferences for timing of pregnancy, importance of avoiding pregnancy, potential changes in fertility preferences, feelings about getting pregnant
  Retrospective fertility preferencesPregnancy wantedness, preferences for timing of pregnancy, importance of avoiding pregnancy, use of family planning before pregnancy, feelings about becoming pregnant
  Ideal number of childrenIdeal number of children
(2) Generic disapproval of pregnancy preventionApproval of/opposition to contraceptive use, importance of features that determine method-choice
(3) Method-specific barriers to useFamiliarity, access, perceived effectiveness, safety, side effects, ease of use, appropriateness of someone like respondent, partner-related factors, satisfaction
(4) Perceived risk of getting pregnantPerceived infecundity, frequency of sexual activity, postpartum insusceptibility, knowledge of safe period during breastfeeding
(5) Partner-related factorsPerceived partner’s fertility preferences, partner’s opposition to contraception
Publication 2017
Child Contraception, Barrier Contraceptive Agents Contraceptive Methods Emergency Contraception Ethnicity Feelings Fertility Generic Drugs HIV Infections Husband Induced Abortions Miscarriage Pregnancy Safety Satisfaction Woman
We analyzed data from the National Health Data System, which provides information on health insurance claims for 99.5% of the population living in France. This database includes individual information on outpatient medical care and drugs. The French lockdown began on March 17, 2020, and was lifted starting on May 11, 2020. We screened all pharmacies' dispensations between January 1, 2018, and June 7 in 2018, 2019, and 2020. Numbers of OC, emergency contraception, LNG-IUD, and ovulation inductor dispensations were measured every week and compared with the numbers of dispensations expected in 2020 without lockdown, on the basis of 2018 and 2019 usage and taking into account the annual trend.
Publication 2021
Emergency Contraception Health Insurance Health Services, Outpatient MLL protein, human Ovulation Pharmaceutical Preparations
The sample size for the study was calculated using Yamane’s formula [7 ] for proportions based on a population of 240 final year female nursing and midwifery students, under the assumption of 95% confidence interval, 5% margin of error, and 20% non-response rate. A sample size of 180 was estimated but was increased to 191 to broaden the scope of the study. The sample size was allocated to the nursing and midwifery programmes using proportion to size approach. Purposive sampling method was then used to sample 100 students from the nursing programme and 91 from the midwifery programme. The students were acquainted with the objective and purpose of the study and informed of their rights during the study. Data for the study were collected with a structured questionnaire on knowledge, perception, and use of emergency contraception. We also collected information on some socio-demographic characteristics (age, marital status, religion, and programme of study) of the students. The questionnaire was designed after considering variables that were included in similar studies. Two senior midwives and a public health professional reviewed the questionnaire for construct and content validity. Then the questionnaire was piloted on 30 first-year nursing and midwifery students to ascertain the clarity and practicability of the questions and to identify poorly constructed items and ambiguities that may be encountered during data collection. Suggested changes from the review and pilot study were made before the actual data collection. Three trained health tutors administered the questionnaire to the nursing and midwifery students in classrooms during school hours.
Publication 2019
Emergency Contraception Females Midwife Student Students, Nursing
This study uses longitudinal data from women and facilities collected in 2011, prior to the start of ISSU program activities (baseline data), and 2015 (endline data) in all six cities. Longitudinal data for women allow us to use fixed effects methods that allow each woman to act as her own control [13] . At baseline, in each city, we collected data from a representative sample of women identified using a two-stage sampling design. In the first stage, we used the 2002 General Population and Housing Census's list of census districts (updated in 2009) as our primary sampling units (PSU) to select a random sample of PSU in each city. On average, census districts contain about 150–200 households. In total, we selected 268 PSU: 64 PSU from Dakar; 32 each from Guédiawaye, Pikine, and Mbao; and 54 each from Mbour and Kaolack. Prior to selection, we worked with municipal leaders to classify neighborhoods as poor and non-poor based on five characteristics: type of housing, residential security, neighborhood density, access to water, and access to flush toilets. Municipal leaders also gave an overall classification of the poverty level of the neighborhood. We weighted the five characteristics of neighborhoods (access to water had a weight of 2; toilets a weight of 1.5; and all others a weight of 1) and then summed. We considered those neighborhoods scoring in the lowest 40% as poor and all others as non-poor. Prior to selection, we stratified PSU by poor and non-poor and half of selected PSU were from the poor strata to increase inclusion of poor households and women. In the selected PSU, we listed/mapped all households and randomly selected 21 households for interview with equal probability [14] .
In total, we selected 5628 households. In each selected household, all women of reproductive age (15–49) were eligible for interview. A trained female interviewer approached all eligible women and asked for their signed consent to participate. At baseline, we interviewed 9614 women across the six cities to provide a representative sample for each city at baseline. At endline, we tracked all baseline women who were usual residents (not visitors) of the household (n=9421) and, if found, asked them for consent to be re-interviewed.
The Institutional Review Board at the University of North Carolina at Chapel Hill and the Comité National d'Ethique in Senegal approved all study procedures.
Women interviewed at both baseline and endline are the analysis sample for examining the impact of the program on modern contraceptive use over the four-year follow-up period. We also undertake a sub-sample analysis of “poor” women, identified from the matched sample as those women who were in the two lowest wealth quintiles (poorest and poor women) at both baseline and endline.
At baseline and endline, we also collected data from health facilities in the study cities. We approached all public and private facilities offering reproductive health services (n=269) for interview. At each study facility, an interviewer administered a facility audit, provider interviews (up to four per facility), and exit interviews [15] .
The key dependent variable for this analysis is use of modern contraception. At baseline and endline, trained interviewers asked women if they were using a contraceptive method to delay or avoid childbearing and if yes, interviewers asked what method the woman was using. Modern methods of contraception include male and female sterilization, daily pill, IUD, implants, injectables, male and female condoms, emergency contraception, Standard Days Method, and lactational amenorrhea. We coded women who reported traditional method use (e.g., rhythm method, withdrawal, or folkloric methods) as non-users. At each time point, we coded women who were abstinent or not sexually active as non-users.
This analysis examines the impact of exposure to various ISSU and non-ISSU demand generation activities and the ISSU and non-ISSU supply-side activities on the probability of modern method use. We classified the exposure variables as demand-side and supply-side. At endline, we included detailed questions on exposure to ISSU specific radio and television activities to assess the contribution of ISSU programming in target cities above and beyond the national-level radio and television programming (see Appendix Table A for details of questions used to measure exposure). We coded each of the exposure variables as dichotomous variables categorized as exposed versus unexposed. All exposure measures that were ISSU-specific and did not exist at baseline were coded zero (unexposed) at baseline.
We included four supply-side variables in this analysis. One of these is specific to the ISSU program: exposure to the ISSU Informed Push Model (IPM). To link the IPM variable to the women's data, we created a variable capturing whether the woman lived within 1 km of a facility with IPM at the time of the endline survey. This variable is coded zero at baseline since the IPM program activity did not exist at that time. We created three other supply variables based on this same 1 km buffer around where women live. These were: (a) woman lives within 1 km of a facility with any stock outs in the last 30 days; (b) woman lives within 1 km of a facility with a quality improvement committee; and c) woman lives within 1 km of a facility with observed FP guidelines.
We undertake descriptive analyses as well as multivariate analyses. We apply fixed effects regression to the pooled samples (baseline and endline) to reduce bias associated with self-selection, recall, and program targeting to underserved areas due to time invariant unobservables. Our estimation methods control for the possibility of endogenous attrition in the endline sample to the extent that attrition is due to unobserved fixed characteristics of the individuals. Fixed effect methods do not control for time varying unobservables. However, given the relatively close spacing of observations, time-varying unobservables are likely not a major source of residual bias in this setting. We estimated a classic fixed effects model whereby changes in modern contraceptive use depend on changes in time-varying individual characteristics and program exposure. All models control for marital status, age, education, city, religion, and wealth (contact corresponding author for full models). We perform two models, one including all women and the other for those in the two lowest wealth quintiles at baseline and endline. All analyses adjust for correlation at the community level using Huber-White type sandwich estimators for standard errors.
Publication 2018
Breast Feeding Buffers Commodes Contraceptive Agents Contraceptive Methods Contraceptives, Oral Emergency Contraception Ethics Committees, Research Female Condoms Females Female Sterilization Flushing Households Injectables Interviewers Males Mental Recall Reproduction Reproductive Health Services Secure resin cement Symptothermal Method of Family Planning Tooth Attrition Woman

Most recents protocols related to «Emergency Contraception»

We trained pharmacy providers to broach the topic of PrEP with clients seeking SRH services associated with risk of HIV acquisition (e.g., condoms and emergency contraception) and to assess interested clients' eligibility for PrEP initiation or refills using a prescription prescribing checklist (Appendix I). The prescribing checklist outlines the core components of pharmacy-delivered PrEP services, including counseling on HIV risk and PrEP eligibility, screening for medical conditions that might contraindicate PrEP safety (e.g., kidney disease), testing for HIV (using provider-assisted HIV self-testing), and prescribing and dispensing PrEP (1 (link)). In cases where pharmacy providers had questions or needed clarification on patient eligibility, a remote clinician was available for consultation via phone call, a secure WhatsApp group, and text message.
Publication 2023
Condoms Eligibility Determination Emergency Contraception Kidney Diseases Patients Safety
Our main outcome is mDFPS, defined as the proportion of women in need of contraception who were using (or whose partner was using) a modern contraceptive method. We considered a woman as in need of contraception if she was sexually active, fecund, and did not want to become pregnant within the next two years, or if she was unsure about whether or when she wanted to become pregnant. We also considered pregnant women with a mistimed or unintended pregnancy as in need of contraception. We considered women as sexually active if they were married or living with a partner, or if they were not married but reported having had sexual intercourse in the month preceding the interview. We classified methods as modern if they were medical procedures or technological products [26 (link)], including oral contraceptive pills, injections, male and female condoms, diaphragms, spermicidal agents, emergency contraception, intrauterine devices (IUD), implants, and sterilization (female or male).
Publication 2023
Coitus Contraceptive Methods Contraceptives, Oral Emergency Contraception Female Condoms Females Fertility Intrauterine Devices Males Pregnant Women Spermatocidal Agents Sterilization, Reproductive Vaginal Diaphragm Woman
Six binary outcome variables were measured: (a) receipt of FP counseling from a community-based health worker who visited the household in the past 12 months; (b) obtaining the current contraceptive method from a community-based health worker (defined to include Momentum nursing students who were community-based distributors); (c) informed choice (i.e., whether the provider informed the FTM about all of the following: other FP methods that she could use, possible side effects or problems that she might have with the method, and what to do if she experienced any side effects or problems, i.e., the MII); (d) current use of implants; (e) current use of injectables; and (f) current use of LARCs vs. short-term modern contraceptive methods (female and male condoms, injectables, pills, Cycle Beads, and emergency contraception). As the analysis was based on users of modern contraceptive methods, women who reported not doing anything to prevent pregnancy and those using traditional methods (withdrawal and rhythm) were not included in the analysis. Secondary outcomes included the FTM's participation in decision making about her current contraceptive method and method satisfaction.
All treatment effect models controlled for baseline measures of age, marital status, years of schooling, ethnicity, parents' education, and weekly television viewing. For dose response, we used multiple measures of intervention exposure: level of exposure categorized as full (participation in both home visits and group education), partial (one of the two) and no exposure (neither); the number of home visits (none, 1–3, 4–6, 7+), the number of group education sessions (none, 1–2, 3–4, 5+), and the total number of exposures to Momentum, defined as the number of home visits plus the number of group education sessions (none, 1–3, 4–6, 7–9, and 10+).
Like the treatment effect models, the multivariable regression model of the choice of LARCs over short-term methods was restricted to women who were currently using a modern contraceptive method at the time of the endline survey. The regression controlled for level of exposure to Momentum interventions (none (comprising users in the comparison health zones as well as 45 users in the intervention health zones who were not exposed to any Momentum interventions), partial (either home visits or group education sessions), and full (both home visits and group education sessions)); receipt of counseling on FP and/or birth spacing during the prenatal period, which was measured at baseline and consisted of the following categories: none, FP or birth spacing, and both FP and birth spacing); being never married at baseline (yes vs. no); Bakongo ethnicity (yes vs. no); worked in the past 12 months at baseline (yes vs. no); awareness of LARCs (a binary variable indicating that the respondent had ever heard of IUDs and implants); and household wealth at baseline [low (reference group), medium, and high]. We also controlled for the FTM's perceived ability to say “no” to unwanted sex (yes vs. no) and to ask her husband/partner to use a condom if she wanted him to (yes vs. no); whether the pregnancy was unintended at baseline (yes vs. no); and age group (15–19 vs. 20–24).
Publication 2023
Age Groups Awareness Community Health Workers Condoms Contraceptive Agents Contraceptive Methods Contraceptives, Oral Emergency Contraception Ethnicity Females Hearing Households Husband Injectables Intrauterine Devices Parent Pregnancy Satisfaction Students, Nursing Visit, Home Woman
Momentum was an integrated FP and maternal and newborn health project. The project sought to increase contraceptive uptake and the adoption of health-seeking behaviors and household practices beneficial to mother and baby, and foster gender-equitable attitudes and behaviors among FTMs age 15–24 years and their male partners in Kinshasa, DRC. The study design was quasi-experimental, with three intervention and three comparison health zones. FTMs were recruited through convenience sampling at high-volume maternal health facilities and community sites and were followed up for 16 months. Enrollment criteria were: (a) six-months pregnant with the first child; (b) willing and mentally competent to provide informed consent; (c) ability to speak French or Lingala; and (d) residence in the intervention or comparison health zones. A total of 1,927 FTMs were completely interviewed in both surveys, of whom 761 were currently using a modern contraceptive.
In intervention health zones, trained nursing students conducted monthly group education sessions and home visits that included client-centered counseling on postpartum FP and birth spacing, offered a range of contraceptive methods (Implanon NXT, Sayana® Press, progestin-only pills, combined oral contraceptive pills, male condoms, emergency contraception, and Cycle Beads), and provided referrals. Group education sessions were based on Program M (21 ), a curriculum that focuses on equitable gender roles, empowerment in interpersonal relationships, and sexual and reproductive health and rights. Each FTM was assigned a dedicated pair of trained nursing students (one male and one female) who conducted monthly home visits in the prenatal and postnatal periods.
Data were collected through face-to-face interviews conducted by trained data collectors at baseline (September to November 2019) and endline (May to July 2020). Pretested questionnaires were used to gather data on the following FP-related topics: background characteristics; knowledge of, attitudes toward, and use of contraceptive methods, perceived norms, informed choice, decision making about contraceptive use, method satisfaction, and exposure to Momentum interventions. Questionnaires were administered using Open Data Kit software and Android smartphones.
Publication 2023
Child Combined Oral Contraceptives Condoms Contraceptive Agents Contraceptive Methods Contraceptives, Oral Emergency Contraception Face Females Households Implanon Infant Males Mothers Progestins Reproduction Satisfaction Sexual Health Students, Nursing Visit, Home

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2023
Caribbean People Contraceptive Agents Contraceptive Methods Contraceptives, Oral Emergencies Emergency Contraception Emergency Contraceptives Ethnic Groups Ethnicity Negroid Races Progestins Reproductive Health Services

Top products related to «Emergency Contraception»

Sourced in United States, Denmark, United Kingdom, Belgium, Japan, Austria, China
Stata 14 is a comprehensive statistical software package that provides a wide range of data analysis and management tools. It is designed to help users organize, analyze, and visualize data effectively. Stata 14 offers a user-friendly interface, advanced statistical methods, and powerful programming capabilities.
Sourced in United States, United Kingdom, Japan, Austria, Germany, Denmark, Czechia, Belgium, Sweden, New Zealand, Spain
SPSS version 25 is a statistical software package developed by IBM. It is designed to analyze and manage data, providing users with a wide range of statistical analysis tools and techniques. The software is widely used in various fields, including academia, research, and business, for data processing, analysis, and reporting purposes.
Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
Sourced in United States, United Kingdom, Japan
SPSS for Windows, version 19.0 is a software package used for statistical analysis. It provides a comprehensive set of tools for data management, analysis, and presentation.
Sourced in United States, Denmark, Austria, United Kingdom
Stata version 13 is a software package designed for data analysis, statistical modeling, and visualization. It provides a comprehensive set of tools for managing, analyzing, and presenting data. Stata 13 offers a wide range of statistical methods, including regression analysis, time-series analysis, and multilevel modeling, among others. The software is suitable for use in various fields, such as economics, social sciences, and medical research.

More about "Emergency Contraception"

Emergency contraception, also known as the 'morning-after pill' or 'post-coital contraception,' is a critical component of reproductive health services.
It provides a safeguard against unintended pregnancy, particularly in cases of unprotected sex, contraceptive failure, or sexual assault.
Researchers in this field leverage a variety of statistical software tools, such as Stata 14, SPSS version 25, SAS version 9.4, SPSS for Windows, version 19.0, and Stata version 13, to analyze data and optimize research protocols.
PubCompare.ai empowers these researchers by enabling them to streamline their work on emergency contraception.
The platform allows users to locate the latest protocols from literature, preprints, and patents, and then leverage AI-driven analysis to identify the most effective protocols and products.
This optimization process helps researchers stay ahead of the curve in this critical area of reproductive health.
Researchers can utilize PubCompare.ai's powerful tools to analyze a wide range of emergency contraception methods, including hormonal contraceptives (such as levonorgestrel and ulipristal acetate), copper intrauterine devices (IUDs), and even natural or traditional approaches.
By comparing the efficacy, safety, and accessibility of these options, researchers can make more informed decisions and develop more effective strategies for promoting reproductive health.
In addition to emergency contraception, PubCompare.ai's capabilities extend to other reproductive health topics, such as fertility treatments, menstrual health, and sexually transmitted infections (STIs).
Researchers can leverage the platform's AI-driven insights to streamline their work, optimize their protocols, and stay at the forefront of these important areas of study.